ArticleAnnals of medicine2026

Prognostic risk modeling based on integrated multi-omics analysis identifies CRY2 as a key regulator in tumor immunity and patient survival in colorectal cancer.

Yu Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.